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Abstract
Tissue Engineering (TE) is  emerging as an effective way of  curing different  tissue
oriented disorders and new tissue regeneration. Here, it has been attempted to show
that biocompatible graphene oxide nanoplatelets (GOnPs)-polymer nanocomposites
are novel materials for the fabrication of TE scaffolds for myoblast differentiation of
human umbilical cord blood derived mesenchymal stem cells (CB-hMSCs). Addition of
GOnPs in bioactive polymers like PCL (poly-caprolactone) and GO-PLGA (poly lactic
co-glycolic acid) enhances electrical conductivity and biocompatibility of the electro-
spun composite scaffolds. CB-hMSCs were used for the direct differentiation to skeletal
muscle cells (hSkMCs) on the electrospun GOnPs–PCL and GOnPs-PLGA nanocom-
posite  scaffolds.  These  scaffolds  exhibited  admirable  myoblast  differentiation,
proliferation and also promoted self-aligned myotubes formation. Moreover, IGF-1 cell
signaling pathway study carried out on GOnPs-PCL composite scaffold meshes also
showed  their  potentiality  for  excellent  myoblast  differentiation  and  proliferation.
Structural,  mechanical,  microstructural  and  vibration  spectroscopic  studies  were
carried out to characterize the scaffold materials. Significantly enhanced values of both
conductivity and dielectric constant provided favorable cues for the increase of cells-
scaffold interaction and biocompatibility of GOnPs based polymer composite scaffolds.
Present  study  confirmed  GOnPs-polymer  composite  scaffolds  as  the  potential
candidates for the myoblast differentiation of CB-hMSCs for skeletal muscle or other
tissues repair and regenerations.
Keywords: umbilical cord blood, mesenchymal stem cells, myoblast differentiation,
graphene oxide, polymer nanocomposite, electrospinning
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1. Introduction
Fabricated artificial scaffolds using suitable biomimetic substrates were found to control the
cellular behaviour and deliver appropriate cues for the differentiation and proliferation of
different  cell  types  for  tissue  engineering  (TE)  applications.  Ideal  scaffolds  directly  or
indirectly help the growth of cells because they interact with the cells. Excellent biocompati-
bility, antibacterial property and mechanical stability of the scaffolds are necessary to provide
adequate  environment  for  cell  growth  and  proliferation.  Over  the  last  decade,  various
nanomaterials (nanodiamond, graphene and carbon nanotubes) have been used along with
suitable polymer to meet the requirements of the desired scaffold materials [1].Among the
various techniques used for the fabrications of scaffolds, electrospinning drew worldwide
attention as  a  simple and effective method [2]  of  preparing scaffold meshes of  different
biocompatible polymers like poly-caprolactone (PCL), polyvinyl alcohol (PVA) and poly(lac-
tic-co-glycolic acid (PLGA)). These polymers have extensively been used for TE and biomed-
ical applications [3–5] because of their appropriate biocompatibility, biodegradability and
good solubility in different organic solvents. However, as the values of both conductivity (σ ~
10−9 S/m) and dielectric permittivity (ε < 10) of most of these bioactive polymers are extremely
small and also highly biodegradable; these polymers alone are not very suitable for many
electronic as well as biomedical applications. Conducting polymers like polyaniline (PANi)
and other solid materials blended with insulating polymers (such as PCL and PLGA PVA)
were found to enhance biocompatibility, biodegradability and better cell scaffolds constructs
[5, 6]. Interestingly, addition of very small amount (~0.3–0.5 wt%) of graphene oxide (GO)
nanoplatelets (GOnPs) in different polymers like poly(methyl methacrylate) (PMMA) [7] and
polyvinyl alcohol (PVA) [8] were reported to enhance both ε and σ values of the resulting
composites  by  2–3  orders  of  magnitudes  along  with  enhancement  of  thermomechanical
stability [8]. Conductivity enhancement of the scaffolds was also reported to provide important
cues for myoblast differentiation [9].
Graphene oxide (GO) or reduced graphene oxide (rGO) are the oxidized forms of graphene.
These oxides possess many oxygen-containing functional groups, such as hydroxyl, carboxyl
and epoxy groups, and they can also adsorb small molecular weight chemical [10] which favour
cell-scaffold interaction and cell viability. Therefore, graphene oxides might be considered as
suitable biocompatible filler materials for making polymer composites for different biomedical
and clinical applications. Moreover, chemically synthesized GO and rGO have also attracted
more interest instead of graphene, in some respects, due to their extraordinary physicochem-
ical properties, ease of synthesis in pure form and fabrication for applications in drug delivery
[11], cancer therapies [12] and TE [13, 14].
Other than scaffolds, another important issue of tissue engineering is the availability of
constant supply of stem cells which are mostly procured from bone marrow (BM), adipose
tissue, etc. It is rather difficult to obtain these stem cells requiring sophisticated surgical
procedures. Moreover, there are also problems to find appropriate donors. However, it has
already been established that human umbilical cord blood, considered to be a biological waste,
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is an import and cost effective source of mesenchymal stem cells (MSCs) and there is immense
scope of utilizing such MSCs for TE and other clinical applications.
In this investigation, GOnPs-impregnated biomimetic PCL and PLGA matrices were prepared
with GO concentration within nontoxicity limit for human cells (≤50/ml [15]) for the fabrication
of fibrous scaffolds by electrospinning technique. The widely used PCL and PLGA were
chosen as the polymer matrices because of their low percolation threshold limit (fc ~ 0.80 wt%
GO) forming homogeneous composites with GOnPs as filler [16]. So far, very little work [6,
10] has been done for the direct differentiation and proliferation of human umbilical cord blood
derived mesenchymal stem cells (CB-hMSCs) on pure biopolymer scaffolds or graphene oxide
(GO)-polymer based composites scaffolds. The use of such biocompatible GO-PCL or GO-
PLGA composite meshes for the myoblast differentiation of CB-hMSCs and oriented myotube
formations are novel and challenging with immense future prospects of in-vivo tissue
regeneration. The confirmation of myoblast differentiation of CB-hMSCs and oriented
myotubes formation on GO-polymer electrospun meshes would also be advantageous for the
next generation TE applications using such antibacterial biocompatible GO-polymer meshes.
Since both PCL and PLGA-graphene oxide nonocomposite meshes exhibited excellent
myoblast differentiation potential, in the present chapter, we shall mainly concentrate our
discussion on the GOnPs-PCl composite system.
2. Synthesis of graphene oxide polymer composites for electrospinning
Graphenene oxide (GO) nanoplatelets (GOnPs), prepared from graphite powder [6], from
homogeneous composites with many bioactive polymers like PVA, PCL, PLGA, chitosan, etc.
[16] in DMSO, chloroform and many other solvents. Electrospinning is a unique technique for
the preparation polymer nanofibres with diameters several micrometres to less than 50 nm.
The electrospun scaffolds for the present study were prepared with GOnPs concentration 30
μg/ml solution as graphene oxide is non-toxic for human cell for its concentration below 50
μg/ml [15]. The electrospinning voltage was kept between 25 and 30 kV.
3. Characterization of GOnPs-polymer composite electrospun scaffold
meshes
Electrospun GO-polymer (like PCL, PLGA or PVA) composite scaffolds showed enhance-
ment of conductivity (σ) dielectric constant (ε) with their threshold values around 0.85
and 0.75wt% of GOnPs , respectively ,  for the case of GO-PCL (Figure 1) and GO-PLGA.
Figure 2a showed the well dispersed GOnPs solution, spin-coated GO film and sheet (prepared
from pure GOnPs water solution). Figure 2b showed the characteristic GO peak appearing at
2θ = 11.1°, corresponding to a lattice d-spacing of 0.78 nm. For the GO-PCL or GO-PLGA
meshes, an XRD peak (Figure 2c) appeared at 21.65° representing the crystalline phase of the
polymer with no peak for GO around 2θ = 11.1°. The absence of GO peak was also reported
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earlier in case of GO-PVA composite [17] which indicated disappearance of the regular and
periodic structure of graphene oxide, the formation of fully exfoliated structures, and the
homogeneous distribution of GOnPs in the polymer matrix [18].
Figure 1. Dependence of (a) effective dielectric constant (ε) and (b) conductivity (σ) of the GO-PCL composite on GO
concentration fGO.
Figure 2. (a) Well dispersed GO-PCL solution (1), a free standing bendable tin GO sheet composed of GOnPs prepared
by solution casting (2) which can be dispersed in water and spin coated GO sheet on cover glass (3) produced from GO
solution. (b) The X-ray diffraction patterns of GO and pristine graphite powder, (c) GO-PCL and PCL, respectively.
The SEM micrograph of a GO sheet surface shown in Figure 3a indicated uniformly rough
surface morphology. Inset of Figure 3a also presented FESEM micrograph showing the surface
morphology of thin GO sheet which indicated wrinkles stacked in multiple GOnPs layers
which favoured cell proliferation.
Figure 3b represented the SEM micrograph of the electrospun fibrous meshes and the selected
area electron diffraction (SAED) pattern (inset of Figure 3b) with (average fibre diameter of
490 ±125 nm and porosity ~80–85%. Figure 3c presented the FESEM micrograph showing
morphology of the broken edge of a GO sheet and inset of Figure 3c showed the HR TEM
image of a single layer of the GOnPs film.
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Figure 3. (a) SEM micrograph showing surface morphology of thin GO sheet (inset shows the FESEM micrographs of a
particular portion the surface). (b) SEM micrograph of the GO-PCL electrospun meshes (inset shows the HRTEM im-
age of GO present in GO-PCL along with the selected area electron diffraction (SAED) image). (c) FESEM micrographs
of a broken edge of thin GO sheet (inset shows the HRTEM image of a single layer GO film). (d) FTIR spectra of GO
sheets and pristine graphite powder (inset) distinguishing the behaviour of graphene and graphite powder. In GO in-
tense bond around 3438 cm−1 corresponding to O–H band of CO–H is observed [6].
Raman is the vibration spectroscopic technique used to characterize GOnPs and identify the
presence of GO in GO-PCL composite. Raman spectra of GO sheet as shown in Figure 4a,
indicated the characteristic feature of GO peaks at frequencies around 1345 and 1597 cm−1,
respectively, for the G and D band usually assigned to the E2g phonon of Csp2 atoms and a
phonon breathing mode of symmetry A1g.Far infra-red (FTIR) spectra of GO and pristine
graphite powder were shown in Figure 4b. The intense band at 3438 cm−1 is attributed to the
O–H band of CO–H. The band at 1639 cm−1 is associated with the stretching of the C═O bond
of carbonyl and carboxyl group.
Figure 4. (a) Raman spectra of GO and GO-PCL composite meshes. (b) FTIR spectra of PCL and GO-PCL mesh distin-
guishing the behaviour of the two spectra. The spectra of GO-PCL if different from those of PCL and GO indicating
strong coupling of GO and the PCL polymer. GO-PCL showed absorption bands at 1727 cm−1 indicating carbonyl
stretching [20].
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Deformation of the C–O bans is observed at the band present at 1070 cm−1. FTIR spectra
(Figure 4b) of GO-PCL showed absorption bands at 1727 cm−1 indicating carbonyl stretch-
ing. The bands appearing at 1295 and 1240 cm−1 represented the C–O and C–C stretching
bonds [19]. The bands at 1239 and 1175 cm−1 were comparable with the asymmetric C–O–C
stretching bonds indicating characteristic absorption [6] of PCL and strong interaction be-
tween GOnPs and polymer matrises.
Figure 5 indicates electrospun GO-PCL composite meshes which degrade up to ~16% in PBS
(phosphate buffer saline) solution whereas electrospun PCL meshes degrade ~9% after 30 days
of time interval. GO-PCL composite mesh showed optimized degradability rate that is suitable
for cellular growth. Hydrophilicity of the GO sheet and GO-PCL composites were measured
by contact angle measurement. Wetting (CAw) and dewetting (CAdw) contact angles of thin GO
sheet and GO-PCL mesh films are shown in Figure 5 (inset). In case of thin GO sheets, CAw
was found to be around ~58.7° with hysteresis (CAw−CAdw) of ~4° which might be a measure
of the solid-liquid interaction [6, 20].
Figure 5. In-vitro degradation pattern of electrospun PCL and GO-PCL composite scaffolds in PBS(phosphate-buffer
solution) for 30 days. Inset shows contact angle analysis (in degrees) representing both advancing (wetting) and reced-
ing (dewetting) water sessile drop on GO sheets, GO-PCL and PCL meshes. Error bars present standard deviation.
The stress-strain curves of GO sheets and GO-PCL meshes were shown in Figure 6. The tensile
strength of PCL (~1.88 ± 0.25 MPa) was found to increase significantly with addition of GO
(~4.8 ± 0.25 MPa). The tensile strength is also known to increase with increasing GO concen-
tration. Favourable mechanical property supported GO-PCL and GO-PLGA meshes for tissue
engineering applications.
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Figure 6. The stress-strain curve of the GO sheet and GO-PCL meshes carried out at RT with GO concentration within
the non-toxic limit (~20 μg/ml) [6].
As shown in Figure 7, GO added PCL (GO-PCL composite) exhibited appreciably large
increase of both ε (~300 for GO-PCL and only ~25 for PCL) and σ (>2 orders of magnitude
higher in GO-PCL compared to that of GO sheet). Similar enhancement of σ and ε was also
observed in GO-polyvinyl alcohol (PVA) and other GO-polymer composites [6, 17].
Figure 7. (a) Room temperature (RT) dielectric constant (ε) and (b) conductivity (σ) data of GO-PCL meshes before
(0 days) and after immersion in PBS solution for up to 7 days. RT ε (c) and σ (d) data of PCL meshes before (indicated
by the 0 days) and after immersion in PBS solution (all measurements were performed 1 kHz).
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Similar conductivity and dielectric constant behaviour (shown in Figure 7) was also observed
in case of GOnPs-PLGA meshes soaked in PBS solution. In this case, enhancement of conduc-
tivity is little lower than those of GOnPs-PCL scaffold meshes indicating little lower biocom-
patibility of the GOnPs-PLGA composite.
4. In-vitro cell culture study
4.1. Isolation and culture of mononuclear cells from UCB
The mononuclear stem cells (MNCs) were isolated from UCB (Figure 8a). Morphology of
MNCs was initially round shaped (after 48 h of culture) shown in Figure 10b via phase contrast
microscope.
Figure 8. (a) Mononuclear cells (MNCs) layer (middle) and red blood cells (RBCs) precipitated at the bottom in a 50 ml
culture tube. (b) Isolation of MNCs being cultured in a cell culture plate.
Figure 9. Gradual morphological changes of umbilical cord blood derived mesenchymal stem cells (MSCs). After fifth
passaging fibroblast like morphology (d) of the cultured cells were observed under phase contrast microscope. Scale
bar: 50 μm.
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Figure 10. Morphology of MSCs analysed using phase contrast microscope (a) and (b) cytoskeleton staining of actin
filaments along with nuclei counterstained with DAPI (fluorescence image).
4.2. Isolation of UCB-derived MNCs
UCB samples were diluted with DMEM media in the ratio of 4:1 before use. The mononuclear
cells (MNCs) were isolated [20] using the Ficoll Hypaque (Histopaque-1077; Sigma, MO, USA)
density gradient centrifugation (with swinging-bucket rotor) at 450 g for 30 min. The eryth-
rocytes were lyzed by incubating with 1% lysis buffer for 10 min and spinning at 200 g for 10
min. The pellet thus obtained was washed twice with phosphate-buffer saline (PBS) by
centrifuging at 200 g for 10 min. Finally, the pellet obtained were culture in DMEM, 10% foetal
bovine serum, 1% antibiotic with addition of 10 ng/ml basic fibroblast growth factor (bFGF).
Initial media was changed after one day to remove the RBC and cell derbies after that media
change after 3-day interval. Cells were then cultured for up to fifth passage.
4.3. Characterization of UCB-derived MSCs by flow cytometry
Cells were analysed by fluorescence-activated cell sorting (FACS) method. In brief, cells were
trypsinized and washed with fluorescence activated cell sorting (BDFACS) buffer. After
centrifugation at 200 g for 5 min at 4°C, cells were suspended in PBS at a concentration of 1 ×
105 cells/ml and repeatedly washed to remove phenol red contained in the media. The cells
were finally suspended in 100 μl of FACS buffer. Cells were then labelled with CD90-FITC,
CD73-PE, CD105-APC, CD45-PE, CD34-FITC and HLA DR-APC monoclonal antibodies at 4°C
for 30 min in the dark. The labelled cells were then analysed by flow cytometry (BDFACS
Fortessa II) with at least 10,000 cells being acquired and analysed.
4.4. Morphological characterization of CB-hMSCs
The morphological variation in the cultured cells was studied by phase contrast microscopic
images (Figure 9). After initial culture, cells were round/spherical shaped during the initial
days of culture and became elongated as spindle fibroblastic shape gradually (Figure 9a–d)
after fifth passage.
The morphology of cells was also analysed using cytoskeleton staining of actin filaments
(Figure 10). Cells (stained with FITC-phalloidin) were observed under a Zeiss Axivert 40 CFL
fluorescence microscope.
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4.5. Immunophenotypic characterization of CB-hMSCs
The immunophenotypic characterizations are shown (Figure 11) to be positive for CD90
(99.2%), CD73(98.5%), CD105 (98%) and negligible for hematopoietic markers like CD45
(1.5%), CD45 (0.5%) and HLA-DR (1.0%) indicating mesenchymal stem cells phenotype.
Similar behaviour was also exhibited by the GO-PLGA meshes [20].
Figure 11. The immunophenotypic analysis was found to be positive for CD90 (99.2%), CD73 (98.5%), CD105 (98%)
and negative for CD45 (1.5%), CD34 (0.5%) and HLA-DR (1.0%) indicating mesenchymal stem cells phenotype.
4.6. Cell metabolic activity
WST-8 assay was used to study the metabolic activity of the MSCs on the prepared scaffolds
on various time intervals. The cellular viability of metabolic activity of the cultured MSCs on
Figure 12. WST-8 assay of CB-hMSCs grown on GO sheet, GO-PCL and control (tissue culture plate) substrates after 3,
7 and 11 days of culture. Superior cellular metabolic activity has been observed on GO-PCL-based composite meshes.
Results presented as the means ± SD. * indicates significant difference (n = 5; p < 0.05). Metabolic activity was increased
with time with the scaffolds showing the trend GO-PCL > GO > control substrate.
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the prepared GO-based scaffold was further evaluated quantitatively by WST-8 assay as shown
in Figure 12.
4.7. Cell proliferation assay (via DNA quantification)
The proliferation of MSCs on the prepared scaffolds was evaluated by DNA quantification
assay. Figure 13 shows an increasing rate in DNA content of MSCs with time as observed in
different GO-based substrates prepared for investigation.
Figure 13. Cell proliferation represented in terms of DNA quantification on GO sheet, GO-PCL mesh and control (tis-
sue culture plate) substrates. An increased trend in DNA content is observed on all the GO-based matrixes. Results
represented as mean ± SD, * indicates significant difference (n = 5; p < 0.05).Proliferation of MSCs were increased with
time with the scaffolds showing the trend GO-PCL > GO > control substrate.
The corresponding DNA contents of hMSCs cultured on tissue culture plate (TCP) was taken
as control, GO sheet and GO-PCL composite meshes on 3–11 days of culture are ~50 to ~285,
~58 to ~375 and ~65 to ~430 ng/ml, respectively.
4.8. MSCs seeding, attachment and spreading
After seeding of MSCs (by static seeding method with ~2×104 cells/ml), attachment and
spreading of these cells was evaluated by scanning electron microscopic (SEM) micrographs
on increasing time interval (Figure 14). Cellular attachment and spreading rate also indicates
their compatibility to the scaffold environment.
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Figure 14. Attachment and spreading of CB-hMSCs on GO-PCL composite scaffolds on days 3 (a), 5 (b) and 7 (c) of
culture. The MSCs are well visualized from the micrographs.
4.9. Differentiation potential of CB-hMSCs on GO-PCL composite meshes
4.9.1. Myoblast differentiation potential
After confirming viability and proliferation of cord blood derived mesenchymal stem cells
(CB-hMSCs or simply MSCs) onto the novel GO-PCL composite scaffolds, MSCs were further
allowed for myoblast differentiation on these substrates. Along with differentiation of MSCs,
elongated bipolar morphology of myoblasts have been observed as seen from FESEM micro-
graphs (Figure 15a and b).
Figure 15. Morphology of CB-MSCs (a) changes towards bipolar structure (b), same as myoblasts, on GO-PCL electro-
spun composite scaffold that indicates differentiation of MSCs to myoblast cells (morphology wise).
4.9.2. Myoblast viability and proliferation
4.9.2.1. Cell viability and proliferation assay
The vastly used methyl thiazolyl diphenyl-tetrazolium bromide (MTT) assay which is a typical
nontoxicity assay may not correctly predict the toxicity of GO because of the mild reaction of
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MTT salt with GO resulting in an incorrect positive signal. Therefore, we used, alternatively,
a water soluble tetrazolium salt (WST-8) assay. Cell viability and proliferation on GO/PCL
composite meshes, thin GO sheet and controls were measured by water-soluble tetrazolium
salt (WST-8) assay after 3, 7and 11 days of cell seeding in 96-well culture plate. Ten microlitre
of cell proliferation reagent (WST-8) was added into each well containing sample with 100 μl
of culture medium and incubated for 4 h at 37°C. Absorbance (OD) of the solution was then
measured at 450 nm by a microplate reader (Varioskan Flash, Thermo Scientific). The cells
seeded on collagen scaffolds were evaluated as control. WST-8 was reduced by dehydrogenase
activities of living cells that give rise yellow-colour formazan dye. The amount of formazan
dye generated (by the activities of dehydrogenases) was directly proportional to the number
of living cells.
4.9.2.2. Evaluation of myotubes formation
For immunostaining analysis, human skeletal myoblast cells (hSkMCs) grown after 5 days of
culture on different substrates (i.e. collagen and glass controls, GO sheets and GO-PCL meshes)
were analysed for the expression of myogenin, an early myogenic differentiation marker.
Briefly, to detect myogenin, cells were fixed and incubated with primary antibody (1:100) at
4°C overnight and after washed with PBS, again incubated with secondary antibody DyLight
488-conjugated goat anti-mouse IgG (1:100) at RT for 1 h. before viewing. On 11 days of culture,
cells were analysed for further expression of muscle specific antigens such as myosin heavy
chain (MHC) and dystrophin. Cells were fixed with 4% paraformaldehyde, permeabilized with
Figure 16. Viability and proliferation of myoblasts observed bytetrazolium salt (WST-8) assay. Superior viability of cells
has been found on GO-PCL composite meshes compare to GO sheet and other controls (collagen and tissue culture
plate) indicating better myoblast differentiation potential and hence biocompatibility. Results presented as the means ±
standard deviation). * indicates significant difference (n = 5; p < 0.05).
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0.1% Triton X-100, and then incubated in goat polyclonal anti-MHC (1:100) and rabbit poly-
clonal anti-dystrophin (1:100) as primary antibodies for 1 h. Next, after washing with PBS, a
FITC conjugate rabbit anti-goat secondary antibody (1:500) was used to detect MHC, while
Texas Red conjugated goat anti-rabbit secondary antibody (1:150) was also employed to detect
dystrophin. Both MHC and Dystrophin are myotubes-specific markers. The samples stained
without primary antibody served as negative controls. Nuclei were counterstained with 4ʹ,6-
diamidino-2-phenylindole (DAPI). Substrates with cells were then mounted for fluorescence
microscopic studies using a Zeiss Axivert 40 CFL fluorescence microscope.
Figure 16 shows viability and proliferation of myoblast cells on GO sheets, GO-PCL mesh and
controls. Cell viability (from WST-8 assay analysis) was found to increase significantly for GO
sheets and GO-PCL meshes compared to the control surfaces (*p < 0.05).
This was ascribed to be due to the better myogenic differential potential contributed by the
favourable physicochemical properties of graphene oxide. This result implied that GO sheets
and GO-PCL meshes were cytocompatible and supported cell viability that increased the
biocompatibility of GO-PCL composite scaffolds.
Figure 17. Myoblast cells viability and proliferation observed by tetrazolium salt (WST-8) assay. Results presented as
mean ± standard deviation. * indicates significant difference (n = 5, p < 0.05). Viability was found to increase with time
on the samples showing the trend of GO-PLGA > GO > control substrate (tissue culture plate).
The viability of myoblast cells on GO-PLGA composite scaffolds were also analysed by
WST-8 assay. Figure 17 showed the viability of GO-PLGA mesh along with control and GO
sheet (for comparison). Cell viability was found to increase significantly on GO sheets and
GO-PLGA meshes compared to that on the control surfaces (*p < 0.05). This result implies
that GO-PLGA mesh is cytocompatible and supported myoblast proliferation as in the case
of GO-PCL composite meshes. It is thus seen that electrospun GO-polymer meshes with low
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GO concentration (not toxic to human cells) provided favourable circumstance for the
growth and proliferation of myoblast cells.
4.9.3. Immunophenotypic characterization of myoblast cells
Flow cytometric analysis of cells adhered on thin GO sheets and GO-PCL meshes was
performed to confirm the positive expression of myogenic markers CD56 and desmin indi-
cating skeletal muscle cell phenotype (Figure 18).
Figure 18. FACS analysis of trypsinized hSkMCs from GO-PCL meshes and GO sheets after 7 days of culture. Cells
were highly expressed for skeletal muscle markers CD56 and desmin indicating myoblast cells phenotype.
4.9.4. Aspect ratio analysis
After 3 days of culture, the aspect ratios measured on GO-PCL meshes, GO sheets and controls
were found to be ~6.6, ~5.4 and (~4.7 for collagen mesh and ~4.3 for tissue culture plate (TCP)),
respectively (Figure 19).
Figure 19. Analysis of cytoskeleton development of hSkMCs grown on (a) control (tissue culture plate (TCP)), (b) colla-
gen mesh, (c) GO sheets, (d) GO-PCL meshes. (e) Cell aspect ratio quantification from (a) to (d) after 3 days of culture.
Increased aspect ratio indicates better elongation of these cells on GO-based substrates.
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4.9.5. Formation of myotubes
The myoblast cells were bipolar at the initial stage (Figure 20a and b) and they were fused
together on extended time interval (day 11) under proper condition and formed myotubes that
were further clarified by FESEM micrograph (Figure 20c) as well as immunostaining assay
(Figure 20d–l). These figures showed improved myoblasts cell proliferation, differentiation
and formation of myotubes onto GO-PCL meshes compared to GO-sheet and control.
Figure 20. FESEM micrographs of GO-PCL electrospun scaffolds representing cells attachment as well as spreading at
increasing time interval (day 3 (a)–day 7 (b)) and also formation of myotubes at extended time of differentiation (day
11 (c)). For better comparison, immunostaining (with desmin-FITC and MHC-FITC conjugated) images of the corre-
sponding FESEM images have also been shown alongside (d–l) with GO sheet and control (tissue culture plate (TCP))
substrate [6, 19].
4.9.6. Immunohistochemical characterization
This process has widely been used for the detection of cells specific antigens (proteins, e.g.
desmin, MyoD, Myosin Heavy Chain, Dystrophin, etc.) to verify the presence of specific cells/
tissues. Immunohistochemical analysis (Figure 21a–l), along with FESEM analysis of the
corresponding samples (Figure 21m–p), confirmed differentiation of CB-hMSCs to myoblasts
via early expression of myogenin-positive nuclei on controls, GO sheet and GO-PCL mesh
(Figure 21a–d).
Moreover, muscle-specific antigens like myosin heavy chain (MHC) shown in Figure 22e–h
and dystrophin (Figure 21i–l) were expressed more intensely on GO-PCL meshes compared
to those on thin GO sheets or control substrates. Myotubes formed on GO sheets and GO-PCL
meshes were found to be more aligned compared to those on the control substrates. Quanti-
tative analysis of the percentage of myogenin-positive nuclei showed in Figure 21 that
myogenin expression increased more on thin GO sheets and GO-PCL meshes compared to
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that on control substrates (collagen mesh and tissue culture plate), which also indicated a better
differentiation potential of the GO-based substrates. Importantly, GO-PCL meshes showed the
highest percentage of myogenin positive nuclei (~19%) (Figure 21). Significantly higher
expression of early myogenic marker (myogenin) indicated superior myogenic differentiation
potential of GO-PCL electrospun meshes compared to GO sheets and controls.
Figure 21. Expression of the early myogenic differentiation marker myogenin-positive nuclei (green) on controls (a and
b), GO sheets (c) and GO-PCL meshes (d). Immunostaining of MHC (green), respectively, on controls (collagen and
tissue culture plate) (e and f), GO sheets (g) and GO-PCL meshes (h) and dystrophin (red) similarly on controls (i and
j), GO sheets (k) and GO-PCL meshes (l). Nuclei were counterstained with DAPI.FESEM micrographs (m–p) of the cor-
responding samples were also shown for better demonstration (q). Quantitative analysis of percentage myogenin-posi-
tive nuclei (cells cultured in differentiation medium for 5 days before staining). * represents significant difference (p <
0.05) compare to collagen mesh and tissue culture plate (TCP) taken as controls [6].
Similar to the GO-PCL composite meshes, immunohistochemical study has also been per-
formed with myoblasts grown on electrospun GO-PLGA meshes. The experimental results
confirmed the differentiation of CB-hMSCs into skeletal myoblasts by the expressions of
desmin and MyoD, and formation of myotubes by the expression of MHC on GO-PLGA
composite meshes and control (tissue culture plate) (Figure 22). Immunostaining of desmin
and MyoD after 3–7 days of culture expressed almost similar on both control and GO-PLGA
substrates. But, formation of MHC on GO-PLGA mesh was much better compare to control.
Formation of myotubes was also more aligned, similar to natural orientation. This indicates
better myotubes formation hence better myogenic maturation potential of GO-PLGA mesh.
But, GO-PCL composite meshes showed even superior myoblast proliferation as well as
differentiation potential compare to GO-PLGA meshes. This might be due to the fact that PLGA
released acidic byproducts upon its degradation that hamper cellular interaction. Moreover,
conductivity of GO-PCL was also higher than that made GO-PLGA mesh that also makes GO-
PCL more suitable for electro-responsive skeletal muscle tissue regeneration.
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Figure 22. Immunostaining of desmin, MyoD and MHC (myosin heavy chain) on control (a–c) and GO-PLGA electro-
spun composite mesh (d–i). Corresponding FESEM micrographs (j–l) of these samples were shown for better demon-
stration. It is revealed that though GO-PLGA showed better myoblast differentiation compared to that on GO sheet.
GO-PCL exhibit superior myoblast differentiation and myotube formation compared to the GO-PLGA meshes [20].
5. Expression of myogenic protein and IGF-1 cell signalling pathway
analysis
The ability of cells to correctly respond to their microenvironment is the basis of tissue repair
and development [21, 22]. Here, myogenic protein expression on GO sheet and electrospun
GO-PCL scaffolds and cell signalling pathway (insulin-like growth factor-1 (IGF-1)) analysis
have been investigated. Better myogenic protein expression was observed on GO-based
polymer composite representing superior myogenic differential potential. It was also observed
that late myogenic protein, myosin heavy chain (MHC) related to the formation of myotubes,
expressed more on GO-PCL composite scaffolds compare to GO sheet and control (tissue
culture plate). Myogenic gene (desmin, MyoD and MHC) expression was also found to be
better on GO based polymer composite substrate. In addition, IGF-1 pathway, important for
skeletal muscle cells growth and maturation [23, 24], was also studied with various intermedi-
ate proteins (IRS-1/PI(3)K/Akt/MyoD) expression. Inhibition of Akt was investigated to
examine the variation of the expression of myogenic protein MyoD, involved in skeletal muscle
differentiation [24, 25]. The expression of MyoD was observed to reduce along with the
inhibition of Akt that indicated effectiveness of IGF-1 pathway for skeletal muscle cells
differentiation and maturation.
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5.1. Expression of myogenic proteins
Expressions of myogenic proteins such as desmin, MyoD and MHC were assessed on GO-PCL
meshes, GO sheet and control (tissue culture plate) using Western blot analysis. Figure 25
showed expressions of desmin and MyoD on these substrates after 5 days of culture. Both of
these proteins expressed well on GO-based substrates. The electroconducting GO-PCL
composite mesh showed the highest expression due to better interconnectivity that enhanced
cellular growth and hence their protein expressions.
Figure 23. Expression of myogenic protein desmin and MyoD (left) and expression of fold change on GO-PCL mesh,
GO sheet and control (tissue culture plate) (right) for the corresponding proteins. * indicates significant difference com-
pare to control (p < 0.05).
From the present observation (Figure 23), the expression levels of desmin and MyoD proteins
were found to be enhanced on grapheme-based scaffolds, compared with to that of control as
follows: 2.4-fold on GO, 4-fold on GO-PCL for desmin and 1.8-fold on GO, 3.1-fold for GO-
PCL for MyoD. Data reported as fold change from control (means ± SE). *indicates significant
differences (n = 5; p < 0.05).
Figure 24. Expression of myogenic protein (MHC) (left) and expression of fold change on control, GO and GO-PCL
substrates (right). * indicates significant difference from control (p < 0.05).
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After 11 days of culture on the same substrates, expression of MHC (a late myogenic marker)
was assessed using Western blot analysis (Figure 24). Expression of MHC, related to formation
of myotubes was found to be better on GO and GO-PCL meshes compared to control substrate.
Here, better expression of this protein in GO-PCL mesh also indicates better myotube forma-
tion on this substrate as described earlier (Figure 23).
The expression levels of MHC protein were found to enhance on GO-PCL composite and GO
sheet compared with that of control: 1.6-fold on GO and 2.5-fold on GO-PCL mesh. Data were
reported as fold change from control (means ± SE).
Figure 25. Expression of myogenic genes (desmin, MyoD and MHC) in myoblasts grown on electrospun GO-PCL
mesh, GO sheet and control (tissue culture plate) substrates. * indicates significant difference from control (p < 0.05).
5.2. Myogenic gene expression
Real-time RT-PCR was used to analyse the expression level of MyoD, desmin and MHC on
GO sheet, GO-PCL scaffolds and control. It was found, similar to protein expression, that these
myogenic genes expressed better on GO-PCL composite and GO sheet.
Highest expression was found on myoblast cells grown on GO-PCL meshes. Quantitative RT-
PCR analysis was performed after differentiation for 5 days for desmin and MyoD and 11 days
for MHC (as MHC express late). As shown in Figure 25, the expression levels of all of the tested
genes were enhanced on graphene derivative and GO-polymer composites, compared with
that of the control as 1.60-fold on GO and 1.98-fold on GO-PCL for desmin; 1.48-fold on GO
and 1.88-fold on GO-PCL for MyoD; 1.86-fold on GO and 2.33-fold on GO-PCL for MHC. *
denotes a significant difference compared to control substrate.
Significant up-regulation of myogenic gene expression indicated that the GO-based substrates
enhanced both early and late stages of myogenic differentiation, subsequently stimulating the
formation of myotubes. In addition, higher expression of myogenic proteins and genes on GO-
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PCL substrates again confirmed its superiority perhaps due to its higher conductivity and
dielectric constant associated with GO surface charge.
5.3. Cell signalling pathway analysis
5.3.1. Insulin-like growth factor 1 (IGF-1) pathway study
IGF-1 is one of the most important pathways that have been studied extensively in the field of
muscle growth [23, 24]. Researchers studied IGF-1/IRS-1/PI(3)K/Akt/MyoD pathway and
concluded its importance for skeletal muscle differentiation and maturation [23–27]. In the
present study, it was attempted to verify this pathway using the novel graphene based
composite scaffolds (Figure 26). IGF-1 is one of the primary mediators of the effects of growth
hormone (GH) in body that stimulates growth via growth promoting effects on almost every
cell, especially muscle cells present in the body. IGF-1 is also capable of regulating cellular
growth and development. In addition, IGF-1/PI3K/Akt pathway prevents expression of muscle
atrophy, very much important for proper development of muscle tissue [24, 28]. So, skeletal
muscle healing is associated with IGF-1.
Figure 26. A schematic representation of IGF-1 cell signalling pathway that is involved in skeletal muscle differentia-
tion and maturation.
5.3.2. Protein expression for IGF pathway
To study IGF pathway, expression of IRS-1/PI(3)K/Akt/MyoD proteins is important. Initially,
the expression of IRS-1/PI(3)K/Akt/MyoD proteins on GO, GO-PCL and control (tissue culture
plate) substrates (Figure 27) was analysed. All of these proteins expressed better on GO and
GO-PCL, while the expression was highest for GO-PCL. This indicates that the GO-PCL
substrate is the most suitable candidate for myoblast differentiation of CB-hMSCs.
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To evaluate IGF-1 pathway, Akt is the most important protein that regulates skeletal muscle
differentiation and hypertrophy. It was also reported that IGF-1 dependent Akt-phosphorali-
zation increased along with higher rate of myogenic differentiation. Properties of MyoD,
responsible for skeletal muscle differentiation, are controlled by Akt and blockage of Akt
prevents formation of skeletal muscle transcriptosome [24–26]. The present investigation
demonstrates that the investigated pathway proteins expressed better on GO-PCL composite
meshes than those on GO sheet or control (tissue culture plate). Up-regulation of such pathway
proteins on GO-PCL further emphasize the IGF-1 pathway which is related to skeletal muscle
development. Thus, it reveals the importance GO-PCL composite meshes for skeletal muscle
tissue engineering applications.
Figure 27. Expression of PI(3)k, Akt, pAkt, IRS-1 (a) and expression of fold change for these corresponding signalling
proteins (b) on control (tissue culture plate), GO sheet and GO-PCL meshes. * indicates significant difference (p < 0.05).
5.3.3. Effect of Akt inhibition on MyoD expression
As mentioned above, Akt is a major component that regulates IGF-1 pathway. Inhibition of
Akt deters IGF-I-stimulated nuclear translocation of Akt and also suppresses the growth of
various cells. Akt is a vital component of the cell survival pathway as it functions by resisting
apoptosis via improving communication between cells that are damaged [26, 27]. Inhibition
of Akt results in much higher rate of apoptosis and a decrease in IGF-1 cell signalling. Inhibition
of Akt was done using 10-DEBC hydrochloride, a selective and precise cell permeable Akt
phosphorylation inhibitor that shows no activity at PDK1, SGK1 or PI 3-kinase [27, 28]. In the
present experiment, the expression of MyoD, a vital myogenic protein that helps in myogenic
differentiation has been studied by pre- and post-Akt inhibition. The results showed (Figure
28) that after inhibition of Akt, the expression of MyoD intensity decreased rapidly. Akt
inhibitor inhibits IGF-I-stimulated nuclear translocation of Akt that results in much reduction
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of MyoD protein assessed by Western blotting. This finding indicates the importance of IGF-1/
IRS-1/PI(3)K/Akt/MyoD cell signalling pathway for the system of present investigation.
Figure 28. Expression of MyoD (a) and the corresponding relative intensity (b) indicating pre- and post-inhibition of
Akt. * indicates significant difference from post Akt inhibition (p < 0.05).
The expressions of myogenic proteins on graphene oxide-based substrates (GO sheet and GO-
PCL scaffold) have been assessed. It has been demonstrated that myogenic proteins expressed
better on the GO-PCL composite meshes than GO sheet and the control (tissue culture plate).
This highlighted the superiority of grapheme-based substrates for myoblast differentiation.
Favourable physicochemical and biological properties established these scaffolds as potential
platforms for myogenic differentiation and maturation for tissue engineering and other
biomedical applications. In addition, we have also shown preliminary study of IGF-1 pathway
that is important for skeletal muscle differentiation and maturation as well. This pathway
proteins (IRS-1/PI(3)K/Akt/MyoD) also expressed better on graphene based substrates,
particularly on GO-PCL scaffolds. Moreover, selective inhibition of Akt has reduced the
expression level of MyoD, a myogenic protein important for skeletal muscle differentiation.
Hence, it was noticed that lower expression of MyoD along with Akt inhibition indicated the
importance of the IGF-1 cell signalling pathway observed from this preliminary investigation.
Further elaborate study seems to be more interesting.
6. Conclusion
ElectrospunGOnPs-PCL and GOnPs-PLGA composite scaffolds showed enhanced conduc-
tivity and dielectric permittivity due to quantum tunnelling between the graphene oxide
nanoflakes. Improved conductivity of the scaffold enhanced biocompatibility of the GOnPs-
polymer composite fibrous meshes compared to those of pure polymers like PCL and PLGA.
As a consequence, the composite scaffolds showed excellent myoblast differentiation of
umbilical cord blood derived mesenchymal stem cells. Increased biocompatibility of GO and
GO-polymer composites were attributed to the surface charge and nanoflake structure of
graphene oxide. Compared to GOnPs-PLGA, GonPs-PCL composite scaffold meshes exhibited
better myoblast differentiation capability which is attributed to the more conducting behaviour
of the GOnPs-PCL composite. IGF-1 cell signalling pathway study carried out on the composite
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scaffold meshes also showed potentiality for excellent myoblast differentiation and prolifera-
tion of cord blood stem cells (CB-hMSCs).Therefore, in demand of cell specific substrates, the
use of GO-based polymer composite meshes might be considered as the most potential
substrates for the next generation tissue engineering and other biomedical applications.
Moreover, it is also worthwhile to mention that cost effective and easily available umbilical
cord blood is an important and abundant source of human stem cells for the differentiation of
skeletal muscle tissues or other lineages.
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